OneMedNet Corporation Form 8-K Summary
Business Context and Reporting Period
OneMedNet Corporation filed a Form 8-K covering events at its virtual 2026 Annual Meeting of Stockholders held on September 18, 2026. The report was signed and dated September 23, 2026. The company’s common stock and redeemable warrants trade on Nasdaq under ONMD and ONMDW, respectively.
Annual Meeting Results and Material Actions
| Proposal | Result | Key Vote |
|---|---|---|
| Election of three Class III directors | Approved | Each nominee received approximately 36.3 million votes for and remained elected to terms expiring at the 2029 annual meeting. |
| Ratification of WithumSmith+Brown, PC | Approved | 41,660,426 for; 138,717 against; 42,309 abstentions. |
| Amended and Restated 2022 Equity Incentive Plan | Approved | 34,528,269 for; 1,868,479 against; 95,735 abstentions; 5,348,969 broker non-votes. |
| Reverse stock split authorization | Approved | 41,068,200 for; 739,329 against; 33,923 abstentions. |
The meeting had 41,841,452 votes represented, equal to 70.57% of the votes entitled to be cast, constituting a quorum.
Equity Plan and Reverse Stock Split
- Stockholders approved an amendment and restatement of the 2022 Equity Incentive Plan, increasing the authorized share reserve by 1,000,000 shares.
- The amended plan became effective immediately upon stockholder approval. Additional equity awards could increase dilution, depending on future grants and share issuance.
- Stockholders authorized the Board of Directors to effect a reverse split of the common stock at a ratio between 1-for-5 and 1-for-20, with the specific ratio to be selected by the Board.
- The filing does not state that the reverse split had been effected, provide an effective date, or identify the ratio selected.
Financial Metrics, Liquidity, Debt, and Outlook
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, balance-sheet information, financial guidance, or operating forecasts. It also does not contain new management commentary regarding business performance or financial outlook.
Risks, Contingencies, and Unusual Items
- The additional 1,000,000 authorized plan shares may result in future equity compensation dilution.
- A potential 1-for-5 to 1-for-20 reverse split could materially reduce the number of shares outstanding and affect per-share trading levels, although the filing does not confirm implementation.
- The filing reports corporate governance and shareholder-authorized actions rather than operating or financial results.
Important Facts for Investors to Verify
- Whether and when the Board implements the authorized reverse stock split and the ratio selected.
- The company’s post-meeting share count, including the effect of the additional equity plan reserve.
- Future equity awards and their potential dilution impact.
- The company’s subsequent financial statements for revenue, cash, liquidity, debt, operating losses, and going-concern or financing risks.
- Any subsequent disclosure regarding the 2026 audit by WithumSmith+Brown, PC.